IntegriChain ranked #391 on Inc. 500 list of fastest growing private companies

IntegriChain, Inc., a leading provider of informatics and data enrichment services to the pharmaceutical industry was identified by Inc. 500 as #391 on the list of fastest growing private companies in America. Despite the general economic slowdown, IntegriChain's innovative approach to leveraging their customers' existing information assets has led to a three year growth rate of over 750%.

"The Inc. 500 list has been the benchmark of achievement for growing companies since 1982," states Kevin Leininger, IntegriChain's CEO. "We are thankful to our customers, our employees, and to Inc. Magazine for recognizing our accomplishment. We certainly aren't done," states Leininger. "We are committed to providing long-term, state of the art solutions for the leverage of information in the next generation of the pharmaceutical industry."

"Helping pharmaceutical companies optimize their business strategies in a challenging economic climate, while leveraging existing information assets is what IntegriChain all about," continues Leininger. "The U.S. pharmaceutical industry spends over $3 Billion on information each year, much of which is redundant, unnecessary and takes too long for companies to make great decisions. Our goal is to minimize the wasteful spending and reduce the time to insight for our customers." IntegriChain works with both large and small pharmaceutical manufacturers in a variety of commercial functions such as finance, trade operations, market research, contract & pricing and brand marketing teams.